The 14th Tokyo Metropolitan Institute of Medical Science Symposium: Bioengineering for Drug Discovery

March 17th (Monday), 2025, 13:00 – 17:00

Tokyo Metropolitan Institute of Medical Science Auditorium

https://www.igakuken.or.jp/public/sympo/sympo14.html

In recent years, revolutionary biotechnology developed in academia, such as iPS cells, mRNA vaccines, and genome editing, has brought about major changes in the fields of medicine, drug discovery, and basic biological research.

However, there are still many diseases that require new therapeutic and diagnostic drugs and the elucidation of disease mechanisms, such as cancer, infectious diseases, and autoimmune diseases. Therefore, in this symposium, we would like to invite researchers who are active at the forefront of bioengineering research to introduce innovative technological developments that lead to drug discovery and elucidation of disease mechanisms, and to deepen the discussion.

“High-speed analysis of acquired immunity and its application to cancer research”

Hidetaka Tanno, Tokyo Metropolitan Institute of Medical Science

“Manufacturing for next-generation medicine based on the modification of small molecules, proteins, and cells

- From the development of a new antigen imaging method to the use of barcoded extracellular vesicles - ”

Ryosuke Kojima, The University of Tokyo

“Principles and applications of optically controllable mononegaviruses”

Makoto Takeda, The University of Tokyo

“Cell-free long circular DNA synthesis technology and its applications”

Masayuki Suetsugu, Rikkyo University

“Synthesis and design of functions of medium-size molecules”

Shinsuke Sando, The University of Tokyo